A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN)-Reference-Cited by-同舟云学术

A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN)

Published:2012-06 Issue:6 Volume:163 Page:931-937.e1
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Van de Werf Frans,Brueckmann Martina,Connolly Stuart J.,Friedman Jeffrey,Granger Christopher B.,Härtter Sebastian,Harper Ruth,Kappetein Arie Pieter,Lehr Thorsten,Mack Michael J.,Noack Herbert,Eikelboom John W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends;Sun;Lancet,2009

2. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses;Cannegieter;Circulation,1994

3. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement;Eitz;Ann Thorac Surg,2008

4. Decreasing warfarin sensitivity during the first three months after heart valve surgery: implications for dosing;Meijer;Thrombosis Research,2010

5. Intensity of oral anticoagulation after implantation of St. Jude aortic prosthesis: analysis of the GELIA database (GELIA 4);Huth;Eur Heart J,2001

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aortic valve 2024: Which valve for which patient?;The Journal of Thoracic and Cardiovascular Surgery;2024-06

2. Is There an Alternative Oral Anticoagulation to Vitamin-K-Antagonists for Patients with Mechanical Aortic Valve Replacement? – A Literature Review;Cardiology and Therapy;2024-05-16

3. 2024 ACC/AHA Clinical Performance and Quality Measures for Adults With Valvular and Structural Heart Disease;Journal of the American College of Cardiology;2024-04

4. 2024 ACC/AHA Clinical Performance and Quality Measures for Adults With Valvular and Structural Heart Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures;Circulation: Cardiovascular Quality and Outcomes;2024-04

5. Revisión sistemática de los ensayos clínicos sobre terapia antitrombótica con inhibidores del factor XI;Revista Clínica Española;2024-03